| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | C-X-C motif chemokine 15|Lungkine|Small-inducible cytokine B15|Cxcl15|Scyb15|Lungkine|Lungkine |
| Assay Time | |
| Detection Method | |
| Detection Range | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | Serum, Plasma, Cell Culture Supernatant, cell or tissue lysate, Other liquid samples |
| Sensitivity | |
| Species | |
| Storage | |
| Target | |
| UniProt # |
Background
mouse CXCL15 (C-X-C motif chemokine 15) is a molecular target commonly studied in immunology, cardiovascular, and cancer research. Chemokines are small secreted proteins that guide immune-cell trafficking and shape inflammatory microenvironments.
Biological role and mechanism
The biological role of CXCL15 is typically understood in terms of its molecular category and interaction network. Depending on the model system, it may participate in cell–cell communication, intracellular signaling, enzymatic processing, or regulation of gene expression programs. Mechanistic interpretation is often strengthened by considering upstream regulators and downstream readouts rather than relying on a single marker.
Expression and abundance of CXCL15 can vary by tissue, cell type, and physiological state. In many systems, levels are influenced by factors such as developmental stage, immune activation, metabolic status, and cellular stress. Because sample matrix and pre-analytical handling can affect measured concentrations, interpretation is typically strongest when experiments keep collection and processing consistent across groups.
Nomenclature and related terms
CXCL15 (C-X-C motif chemokine 15) may also be referenced as C-X-C motif chemokine 15, Lungkine, and Small-inducible cytokine B15 in the literature or in databases. When comparing results across studies, confirm that the reported analyte refers to the same molecule, species context, and molecular form (e.g., precursor vs mature protein, or soluble vs membrane-associated forms).
Why it matters in research
- Understanding how CXCL15 relates to innate and adaptive immune responses, cytokine signaling networks, host–pathogen interactions, and immune cell activation and trafficking in immunology, cardiovascular, and cancer research.
- Interpreting shifts in CXCL15 levels alongside other pathway components or complementary markers.
- Connecting molecular changes to phenotypes such as inflammation, remodeling, metabolism shifts, or cell-state transitions (context-dependent).
Molecular forms and interpretation
For some targets, isoforms, proteolytic processing, or post-translational modifications (such as phosphorylation or glycosylation) can influence function and apparent abundance. If multiple molecular forms are expected in your model, align interpretation with the form most relevant to the biological question.
Disease and translational relevance
CXCL15 has been investigated across diverse physiological and disease contexts, and changes in its abundance have been reported in areas aligned with immunology, cardiovascular, and cancer studies. These associations are interpreted as research findings rather than diagnostic or therapeutic claims, and they should be evaluated alongside model-specific covariates and study design.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
Vitamin D3 and carbamazepine protect against Clostridioides difficile infection in mice by restoring macrophage lysosome acidification
IF: 16.016 Journal: Autophagy Cited Date: 2022-01-13
Exosomal miR-129-2-3p promotes airway epithelial barrier disruption in PM2.5-aggravated asthma
IF: 8 Journal: Journal of Environmental Management Author: Department of Environmental Health, School of Public Health, Shanxi Medical University, China. Cited Date: 2024-11-08
Gut microbiota-derived acetic acids promoted sepsis-induced acute respiratory distress syndrome by delaying neutrophil apoptosis through FABP4
IF: 6.2 Journal: Cellular and Molecular Life Sciences Author: Department of Respiratory and Critical Care Medicine, Henan Provincial People's Hospital (People's Hospital of Zhengzhou University), Zhengzhou, China. Cited Date: 2024-11-01
Mechanism of action of M-XQLD treatment for asthma: role of STARD13 in Th17 suppression
IF: 5.4 Journal: Inflammation Research Author: Department of Pediatrics, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, Henan, China. Cited Date: 2025-10-17
Finerenone Alleviates Over-Activation of Complement C5a-C5aR1 Axis of Macrophages by Regulating G Protein Subunit Alpha i2 to Improve Diabetic Nephropathy
IF: 5.1 Journal: Cells Author: Renal Division, Department of Medicine, Peking University First Hospital, Beijing 100034, China Cited Date: 2025-03-07
Antiviral and immunoregulatory effects of curcumin on coxsackievirus B3-infected hepatitis
IF: 5 Journal: Virus Research Author: Department of Microbiology & Immunology, College of Medicine, National Cheng Kung University, Tainan 70101, Taiwan Cited Date: 2023-09-08
Ephedrine ameliorates chronic obstructive pulmonary disease (COPD) through restraining endoplasmic reticulum (ER) stress in vitro and in vivo
IF: 4.932 Journal: International Immunopharmacology Cited Date: 2021-12-31
The impact of TLR7 agonist R848 treatment on mast cell phenotype and activity
IF: 4.078 Journal: Cellular Immunology Cited Date: 2020-11-19
Yu-Ping-Feng-San mitigates development of emphysema and its exacerbation induced by influenza virus in mice
IF: 3.8 Journal: Chinese Herbal Medicines Author: State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510000, China Cited Date: 2024-02-18